130 related articles for article (PubMed ID: 17574288)
1. Beta-lapachone-containing PEG-PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells.
Blanco E; Bey EA; Dong Y; Weinberg BD; Sutton DM; Boothman DA; Gao J
J Control Release; 2007 Oct; 122(3):365-74. PubMed ID: 17574288
[TBL] [Abstract][Full Text] [Related]
2. Prodrug strategy to achieve lyophilizable, high drug loading micelle formulations through diester derivatives of β-Lapachone.
Ma X; Huang X; Huang G; Li L; Wang Y; Luo X; Boothman DA; Gao J
Adv Healthc Mater; 2014 Aug; 3(8):1210-6. PubMed ID: 24532286
[TBL] [Abstract][Full Text] [Related]
3. Lysosome-oriented, dual-stage pH-responsive polymeric micelles for β-Lapachone delivery.
Zhou Y; Dong Y; Huang G; Wang Y; Huang X; Zhang F; Boothman DA; Gao J; Liang W
J Mater Chem B; 2016 Dec; 4(46):7429-7440. PubMed ID: 28580145
[TBL] [Abstract][Full Text] [Related]
4. NAMPT inhibition sensitizes pancreatic adenocarcinoma cells to tumor-selective, PAR-independent metabolic catastrophe and cell death induced by β-lapachone.
Moore Z; Chakrabarti G; Luo X; Ali A; Hu Z; Fattah FJ; Vemireddy R; DeBerardinis RJ; Brekken RA; Boothman DA
Cell Death Dis; 2015 Jan; 6(1):e1599. PubMed ID: 25590809
[TBL] [Abstract][Full Text] [Related]
5. Following anticancer drug activity in cell lysates with DNA devices.
Kahanda D; Singh N; Boothman DA; Slinker JD
Biosens Bioelectron; 2018 Nov; 119():1-9. PubMed ID: 30098460
[TBL] [Abstract][Full Text] [Related]
6. Tailored Beta-Lapachone Nanomedicines for Cancer-Specific Therapy.
Li Y; Feng M; Guo T; Wang Z; Zhao Y
Adv Healthc Mater; 2023 Aug; 12(20):e2300349. PubMed ID: 36970948
[TBL] [Abstract][Full Text] [Related]
7. Beta-lapachone suppresses radiation-induced activation of nuclear factor-kappaB.
Dong GZ; Oh ET; Lee H; Park MT; Song CW; Park HJ
Exp Mol Med; 2010 May; 42(5):327-34. PubMed ID: 20200474
[TBL] [Abstract][Full Text] [Related]
8. Synergistic Effect of β-Lapachone and Aminooxyacetic Acid on Central Metabolism in Breast Cancer.
Chang MC; Mahar R; McLeod MA; Giacalone AG; Huang X; Boothman DA; Merritt ME
Nutrients; 2022 Jul; 14(15):. PubMed ID: 35893874
[TBL] [Abstract][Full Text] [Related]
9. β-lapachone regulates mammalian inositol pyrophosphate levels in an NQO1- and oxygen-dependent manner.
Eisenbeis VB; Qiu D; Gorka O; Strotmann L; Liu G; Prucker I; Su XB; Wilson MSC; Ritter K; Loenarz C; Groß O; Saiardi A; Jessen HJ
Proc Natl Acad Sci U S A; 2023 Aug; 120(34):e2306868120. PubMed ID: 37579180
[TBL] [Abstract][Full Text] [Related]
10. A Novel Redox-Sensitive Drug Delivery System Based on Trimethyl-Locked Polycarbonate.
Wang D; Li M; Zhang H; Feng C; Wu L; Yan L
Biomacromolecules; 2023 Sep; 24(9):4303-4315. PubMed ID: 37585690
[TBL] [Abstract][Full Text] [Related]
11. β-Lapachone, an NQO1 bioactivatable drug, prevents lung tumorigenesis in mice.
Chen Y; Wu R; Li X; Cao M; Yang M; Fu B; Xuan C; Chen C; Zhou Y; Hu R
Eur J Pharmacol; 2024 Jun; 973():176511. PubMed ID: 38604545
[TBL] [Abstract][Full Text] [Related]
12. β-Lapachone Selectively Kills Hepatocellular Carcinoma Cells by Targeting NQO1 to Induce Extensive DNA Damage and PARP1 Hyperactivation.
Zhao W; Jiang L; Fang T; Fang F; Liu Y; Zhao Y; You Y; Zhou H; Su X; Wang J; Liu S; Chen Y; Wan J; Huang X
Front Oncol; 2021; 11():747282. PubMed ID: 34676172
[TBL] [Abstract][Full Text] [Related]
13. Discovery of Isoplumbagin as a Novel NQO1 Substrate and Anti-Cancer Quinone.
Tsao YC; Chang YJ; Wang CH; Chen L
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575541
[TBL] [Abstract][Full Text] [Related]
14. Mesoporous Silica Nanoparticle-Based Combination of NQO1 Inhibitor and 5-Fluorouracil for Potent Antitumor Effect Against Head and Neck Squamous Cell Carcinoma (HNSCC).
Chen J; Zhang S; Zhang S; Gao S; Wang J; Lei D; Du P; Xu Z; Zhu C; Sun H
Nanoscale Res Lett; 2019 Dec; 14(1):387. PubMed ID: 31858276
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Chemodynamic Therapy Mediated by a Tumor-Specific Catalyst in Synergy with Mitophagy Inhibition Improves the Efficacy for Endometrial Cancer.
Gong X; Wang J; Yang L; Li L; Gao X; Sun X; Bai J; Liu J; Pu X; Wang Y
Small; 2023 Aug; 19(33):e2301497. PubMed ID: 37086131
[TBL] [Abstract][Full Text] [Related]
16. Lipid-assisted PEG-
Huang X; Li J; Yang Y; Wang ZL; Yang XZ; Lu ZD; Xu CF
Biomater Sci; 2023 Nov; 11(22):7445-7457. PubMed ID: 37819252
[TBL] [Abstract][Full Text] [Related]
17. Augmented Concentration of Isopentyl-Deoxynyboquinone in Tumors Selectively Kills NAD(P)H Quinone Oxidoreductase 1-Positive Cancer Cells through Programmed Necrotic and Apoptotic Mechanisms.
Wang J; Su X; Jiang L; Boudreau MW; Chatkewitz LE; Kilgore JA; Zahid KR; Williams NS; Chen Y; Liu S; Hergenrother PJ; Huang X
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136388
[TBL] [Abstract][Full Text] [Related]
18. Measuring NQO1 Bioactivation Using [
Mahar R; Chang MC; Merritt ME
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439319
[TBL] [Abstract][Full Text] [Related]
19. Impact of Micellar Vehicles on in situ Intestinal Absorption Properties of Beta-Lapachone in Rats.
Jang SB; Kim D; Kim SY; Park C; Jeong JH; Kuh HJ; Lee J
Korean J Physiol Pharmacol; 2013 Feb; 17(1):9-13. PubMed ID: 23440944
[TBL] [Abstract][Full Text] [Related]
20. Colocalized delivery of rapamycin and paclitaxel to tumors enhances synergistic targeting of the PI3K/Akt/mTOR pathway.
Blanco E; Sangai T; Wu S; Hsiao A; Ruiz-Esparza GU; Gonzalez-Delgado CA; Cara FE; Granados-Principal S; Evans KW; Akcakanat A; Wang Y; Do KA; Meric-Bernstam F; Ferrari M
Mol Ther; 2014 Jul; 22(7):1310-1319. PubMed ID: 24569835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
